Joshua T. Kantrowitz, MD

  • 5Articles
  • 18.7KReads
  • 2015–2025Active
  • 16Collaborators
  • 195Citations

About

Joshua T. Kantrowitz, MD, is affiliated with the New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, and the Nathan Kline Institute. His publications from 2015 to 2025 focus on schizophrenia and schizoaffective disorders, bipolar disorder, major depressive disorder, and weight management in psychiatric treatment. His research includes studies on cognitive remediation therapy combined with lurasidone, the use of ketamine and d-cycloserine in treatment-resistant bipolar depression, and challenges in administering semaglutide with long-term olanzapine use.

Publications

JCP
Administering Semaglutide With Long-Term Olanzapine Use
Case Report

Administering Semaglutide With Long-Term Olanzapine Use

June 9, 2025

This report describes use of the GLP-1R agonist semaglutide in a patient with schizophrenia and severe, olanzapine-induced weight gain that was resistant to alternative treatments.
, , , et al
JCP
Letter to the Editor

Dr Kantrowitz and Colleagues Reply

October 26, 2016

, , , et al
JCP
Letter to the Editor

Dr Kantrowitz and Colleagues Reply to Efficacy of Auditory Processing-Focused Cognitive Remediation Therapy

August 24, 2016

, ,
JCP
Original Research

Cognitive Remediation and Lurasidone in Schizophrenia

June 22, 2016

What is the best cognitive remediation method to use as an adjunct with lurasidone to help your patients with schizophrenia? These researchers compared auditory processing cognitive remediation against videogames....
, , , et al
JCP
Letter to the Editor

Ketamine Treatments for Depression

June 24, 2015

Does single-dose Ketamine Followed by Daily d-Cycloserine act as a Treatment to Resistant Bipolar Depression? Read this study to learn more.
, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe